Management of Severe Pregnancy-Induced Hypertension

Immediate Blood Pressure Management

• The European Society of Cardiology recommends immediate antihypertensive treatment for severe PIH (BP ≥160/110 mmHg), with intravenous labetalol as the first-line agent, targeting BP reduction to 140-150/90-100 mmHg within 15-60 minutes 1, 2
• Severe PIH is defined as BP ≥160/110 mmHg, and BP >160/110 mmHg lasting >15 minutes warrants immediate drug treatment 1, 2
• The immediate goal is to decrease mean BP by 15-25%, targeting SBP 140-150 mmHg and DBP 90-100 mmHg 1, 3

First-Line Antihypertensive Agents

• Labetalol IV is considered safe and effective for severe pre-eclampsia, with a recommended dosing of bolus administration, which can be given repeatedly until BP controlled 1, 3, 2
• The American College of Cardiology recommends oral labetalol: 100 mg twice daily, up to 2400 mg/day for ongoing management, as an alternative to IV labetalol 4

Seizure Prophylaxis

• The American College of Obstetricians and Gynecologists recommends magnesium sulfate administration for prevention of eclampsia and treatment of seizures in severe PIH, but it should NOT be given concomitantly with calcium channel blockers due to risk of severe hypotension from synergistic effects 2, 4

Special Circumstance: Pulmonary Edema

• The European Society of Cardiology recommends nitroglycerin (glycerol trinitrate) IV infusion as the drug of choice for pulmonary edema, starting at 5 mcg/min, increasing every 3-5 minutes to maximum 100 mcg/min 1, 3

Critical Monitoring Requirements

• The European Society of Cardiology recommends monitoring for maternal early warning criteria, including SBP <90 or >160 mmHg, DBP >100 mmHg, heart rate <50 or >130 bpm, oxygen saturation <95% on room air, oliguria, altered mental status, non-remitting headache, and shortness of breath 1, 2, 3

Timing of Delivery

• The American College of Obstetricians and Gynecologists recommends delivery as the definitive treatment for severe PIH, with induction of labor recommended at 37 weeks gestation for gestational hypertension or mild pre-eclampsia, and immediate delivery indicated for severe heart failure and/or fetal distress 2, 3, 4

Medications to AVOID

• The European Society of Cardiology recommends avoiding ACE inhibitors, angiotensin receptor blockers (ARBs), and direct renin inhibitors due to severe fetotoxicity, particularly in second and third trimesters 2, 6

Postpartum Considerations

• The American College of Cardiology recommends monitoring for postpartum complications, including stroke and eclampsia, and notes that hypertension should resolve within 6-12 weeks postpartum; persistence suggests pre-existing hypertension 2

Common Pitfalls to Avoid

• The European Society of Cardiology recommends avoiding delay in treatment, combining nifedipine with magnesium sulfate, using short-acting oral nifedipine as first-line, restricting salt intake, and using diuretics for pulmonary edema in pre-eclampsia 1, 2, 3, 5, 6